Nickel and poultry torch a coal-and-bank slog
Contents
This season's defining split is not between sectors but between momentum and mass. The top of the table is a narrow, violent pocket of commodity and protein upcycles — nickel mining at +27.3% median revenue growth, poultry and feed at +19.2% — while the broad, heavy end of the market barely moves: banks at +4.9%, telecom at +3.9%, and two sectors outright shrinking, conglomerates at -3.0% and gas distribution at -3.8%. The gap between the best and worst industry median is more than 31 percentage points, and that is the whole story.
Revenue growth by industry (median YoY)
Nickel and poultry delivered the cleanest operating leverage
INCO is the season's standout: revenue up 27.3% year over year and net profit up 313.4%, a profit explosion that dwarfs its top-line move and signals a genuine margin re-rating in nickel. CPIN is the non-commodity equivalent — revenue +19.2%, EBITDA +56.8%, net profit +95.1% — proof that poultry and feed can compound earnings nearly as fast as a metal spike when input costs cooperate. Both sit in single-name industries, so their medians are their own results, but the magnitude is real.
Coal is not dead either, just uneven. PTBA posted revenue +7.7% but EBITDA +96.6% and net profit +214.7%, a stunning profit rebound from a prior period where revenue was -0.3% and net profit +104.8%. ADRO added revenue +16.5% and net profit +68.9%, while ITMG was the laggard of the group at revenue +8.8% and net profit +16.5%. The coal median of +8.8% hides a wide dispersion: the best name in the group grew profit more than 13 times faster than the weakest.
The conglomerate and gas patch are the season's warning signs
ASII is the clearest loser: revenue -3.0%, EBITDA -20.3%, net profit -19.2%, and the deterioration is broad rather than a one-off. PGAS is uglier on the operating line — revenue -3.8% and EBITDA -40.5% — even though net profit rose 45.8%, a result that looks more like a below-the-line item than an operating recovery. And BMRI is the bank that broke the sector's calm: revenue -8.7% year over year, a sharp deceleration from -1.8% in the prior period, even as net profit rose 17.8%. When revenue falls nearly 9% and profit rises, the quality of that profit deserves a hard look.
The plot twist: BMRI's profit accelerated while its revenue collapsed
The most interesting divergence is inside BMRI. Net profit growth accelerated from +11.6% in the prior period to +17.8% now, even as revenue slowed from -1.8% to -8.7%. That is the opposite of operating leverage — it is financial engineering, cost cuts, or one-off gains carrying the bottom line. By contrast, PTBA is the clean acceleration: net profit growth sped up from +104.8% to +214.7%, and this time revenue turned positive at +7.7% from -0.3%. One is a warning, the other a genuine upcycle.
Cheap for the growth: CPIN and INDF look mispriced, SMGR does not
CPIN is the value standout: net profit up 95.1% yet trading at just 6.1x earnings and 3.9x EV/EBITDA — a poultry compounder priced like a no-growth staple. INDF is even cheaper at 6.2x earnings and 1.9x EV/EBITDA, though its net profit fell 19.1%, so the multiple is a bet on margin recovery rather than momentum. INCO, growing profit 313.4%, trades at 14.3x earnings and 10.1x EV/EBITDA — not outrageous for that growth, but no longer a bargain. SMGR is the opposite: revenue +13.1% but a P/E of 52.4x, priced for perfection with no visible EBITDA support in the data. GOTO at 71.9x EV/EBITDA is the most speculative multiple in the set, justified only if its +157.0% net profit growth is durable.
Income: banks and coal pay you to wait
The data provided does not include dividend yields or DPS figures, so an income ranking cannot be constructed from these numbers alone. What can be said is that the cheapest cash-generative names — BMRI at 5.5x earnings, ASII at 5.5x, INDF at 6.2x — are the natural candidates for income investors, but yield must be verified separately before acting.
The long view belongs to the accelerators, not the level-setters. PTBA's profit growth more than doubled from +104.8% to +214.7%, and CPIN's net profit accelerated from +67.7% to +95.1% — both are improving, not just high. Watch next whether INCO's 313.4% profit growth is a peak or a plateau, and whether BMRI's revenue decline deepens into a real earnings problem. The season's message is simple: pay for momentum where it is cheap, and demand proof where the multiple is rich.
Players: growth & yield (no absolute levels)
| Company | Industry | Revenue YoY | EBITDA YoY | Net profit YoY | P/E |
|---|---|---|---|---|---|
| ASII (H1) | Conglomerate | -3.0% | -20.3% | -19.2% | 5.5x |
| BBRI (H1) | Banks | +9.9% | n/a | +17.5% | 7.2x |
| TLKM (H1) | Telecom | +3.9% | +3.4% | -3.2% | 13.5x |
| INDF (H1) | Consumer staples | +9.5% | +12.5% | -19.1% | 6.2x |
| ANTM (H1) | Metals mining | +6.3% | +33.0% | +36.0% | 7.7x |
| BMRI (H1) | Banks | -8.7% | n/a | +17.8% | 5.5x |
| BBCA (H1) | Banks | -0.2% | n/a | +1.8% | 10.6x |
| ICBP (H1) | Consumer staples | +11.3% | +8.0% | -33.1% | 9.4x |
| CPIN (H1) | Poultry and feed | +19.2% | +56.8% | +95.1% | 6.1x |
| UNVR (9M) | Consumer staples | -6.7% | — | +26.0% | 6.3x |
| BBNI (H1) | Banks | +14.2% | n/a | +6.6% | 6.2x |
| PTBA (H1) | Coal mining | +7.7% | +96.6% | +214.7% | 8.0x |
| KLBF (H1) | Pharmaceuticals | +14.0% | -2.5% | -2.8% | 9.0x |
| SMGR (H1) | Cement | +13.1% | — | n/m | 52.4x |